SAKAR HEALTHCARE
Back to Cashflow Statement
|
SAKAR HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|
Cash Flow from Financing Activities | ₹41 Cr | ₹55 Cr | ₹32 Cr | ₹3.48 Cr |
What is the latest Cash Flow from Financing Activities ratio of SAKAR HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹41 Cr |
Mar2022 | ₹55 Cr |
Mar2021 | ₹32 Cr |
Mar2020 | ₹3.48 Cr |
How is Cash Flow from Financing Activities of SAKAR HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹41 Cr | -24.76 | |
Mar2022 | ₹55 Cr | 70.51 | |
Mar2021 | ₹32 Cr | 820.22 | |
Mar2020 | ₹3.48 Cr | - |
Compare Cash Flow from Financing Activities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹767.2 Cr | -0.8% | -2.8% | 65.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -0.8% |
-2.8% |
65.6% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses